CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 33 enrolled
Drug / intervention
oral levofloxacin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01988779
NCT01988779Phase 3Completed

Oral Versus Topical Antibiotic Therapy for Treatment of Chronic Rhinosinusitis Exacerbations

University of Rochester·interventional·Posted Nov 20, 2013·Updated Mar 24, 2021

In Brief

A Phase 3 clinical trial evaluating oral levofloxacin and nebulized levofloxacin for Chronic Rhinosinusitis. Completed, enrolled 33 participants across 1 site.

Detailed Summary

The purpose of this study is to treat patients with a diagnosis of chronic rhinosinusitis (CRS) and a history of bilateral endoscopic sinus surgery during times of worsening symptoms and signs of acute infection on nasal endoscopy with one of two treatments: (1) oral antibiotics and twice daily intranasal saline irrigations or (2) oral placebo and twice daily intranasal antibiotic irrigations. The two treatments will be compared to see if there is any difference in patient outcomes. This will help guide treatment strategies for patients with CRS in the future.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 20, 2013
Enrollment StartOct 1, 2013
Primary CompletionSep 11, 2017
Study CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 12.6 years ago

Interventions

oral levofloxacindrug

nebulized levofloxacindrug